We are live on ! Find out more
VTAE

VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE

Delisted

VTAE was delisted on the 24th of October, 2016.

Back to rankings

53 hedge funds and large institutions have $193M invested in VITAE PHARMACEUTICALS INC COMMON STOCK in 2015 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 8 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

188% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 8

40% more capital invested

Capital invested by funds: $138M → $193M (+$54.7M)

2% more funds holding

Funds holding: 52 → 53 (+1)

7% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 14

Holders
53
Holders Change
+1
Holders Change %
+1.92%
% of All Funds
1.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
23
Reduced
8
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$8.49M
2
Millennium Management
Millennium Management
New York
+$7.97M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$5.36M
4
BFA
BlackRock Fund Advisors
California
+$2.24M
5
PA
Perceptive Advisors
New York
+$2.04M

Top Sellers

Rank Fund Capital Flow
1
WT
Wellcome Trust
United Kingdom
-$4.95M
2
Goldman Sachs
Goldman Sachs
New York
-$1.9M
3
GCP
GSA Capital Partners
United Kingdom
-$807K
4
BIT
BlackRock Institutional Trust
California
-$609K
5
HCM
Highbridge Capital Management
New York
-$414K
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$377K +$127K +9,388 +56%
Charles Schwab
27
Charles Schwab
California
$377K +$158K +11,652 +81%
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$349K +$166K +12,227 +102%
PC
29
Polar Capital
United Kingdom
$320K – – –
AA
30
ALPS Advisors
Colorado
$312K +$294K +21,678 New
TA
31
Teachers Advisors
New York
$278K +$147K +10,794 +126%
TC
32
TFS Capital
Pennsylvania
$214K +$202K +14,889 New
New York State Common Retirement Fund
33
New York State Common Retirement Fund
New York
$164K +$155K +11,400 New
RhumbLine Advisers
34
RhumbLine Advisers
Massachusetts
$148K +$140K +10,285 New
BCM
35
Bridgeway Capital Management
Texas
$145K +$137K +10,100 New
NFA
36
Nationwide Fund Advisors
Ohio
$123K +$50K +3,679 +76%
Bank of Montreal
37
Bank of Montreal
Ontario, Canada
$115K -$363K -26,715 -77%
AIG
38
American International Group
New York
$112K +$57.6K +4,245 +120%
Deutsche Bank
39
Deutsche Bank
Germany
$100K +$96.2K +7,086 +708,600%
Morgan Stanley
40
Morgan Stanley
New York
$50K -$37K -2,721 -44%
TRCT
41
Tower Research Capital (TRC)
New York
$44K +$41.7K +3,073 New
CG
42
Colony Group
Massachusetts
$31K +$29.5K +2,173 New
UBS Group
43
UBS Group
Switzerland
$29K +$27.1K +1,995 New
SO
44
STRS Ohio
Ohio
$27K – – –
BNP Paribas Financial Markets
45
BNP Paribas Financial Markets
France
$15.9K +$13K +960 +667%
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
$14K +$13.5K +995 New
Wells Fargo
47
Wells Fargo
California
$10K -$19.8K -1,455 -69%
Bank of America
48
Bank of America
North Carolina
$6K +$5.62K +414 +2,435%
Invesco
49
Invesco
Georgia
$5K +$4.54K +334 New
Barclays
50
Barclays
United Kingdom
$4K +$720 +53 +27%
1
2
3

VTAE Hedge Fund Activity: Q2 2015 in Review

53 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) for Q2 2015, worth a combined $193M — up 40% from $138M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new VTAE positions and 14 closed out — a net gain of 1 holder — while 23 added to existing stakes and 8 trimmed.

The largest buyer was Adage Capital Partners, adding an estimated $8.49M. The largest seller was Wellcome Trust, exiting entirely with an estimated $4.95M sold.

  • 53 institutional investors held VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) as of Q2 2015, up from 52 in Q1 2015.
  • Funds reported $193M of VITAE PHARMACEUTICALS INC COMMON STOCK stock for Q2 2015, up 40% quarter-over-quarter.
  • 15 funds opened new VITAE PHARMACEUTICALS INC COMMON STOCK positions in Q2 2015 and 14 closed out, a net change of +1 holder.
  • The largest VITAE PHARMACEUTICALS INC COMMON STOCK buyer in Q2 2015 was Adage Capital Partners, an estimated $8.49M added.
  • The largest VITAE PHARMACEUTICALS INC COMMON STOCK seller in Q2 2015 was Wellcome Trust, an estimated $4.95M sold.

Based on aggregated 13F filings for Q2 2015.